文献速递主动脉疾病

基质金属蛋白酶与主动脉瘤:一项两样本孟德尔随机化研究

Matrix Metalloproteinase and Aortic Aneurysm: A Two-sample Mendelian Randomization Study.
PubMed 文献 · Ann Vasc Surg · 2024-04-10

该研究采用两样本孟德尔随机化方法,纳入8种基质金属蛋白酶(MMP)与胸主动脉瘤(TAA)及腹主动脉瘤(AAA)的全基因组关联研究数据(TAA与AAA分别来自FinnGen联盟,共3,201例病例和317,899例对照),发现血清MMP-12水平与TAA和AAA风险呈负向因果关联,未发现水平多效性或异质性。

要点

  • 血清MMP-12每升高1 ng/mL,TAA发生风险降低(OR=0.897,95%CI:0.831-0.968,P=0.005)。
  • 血清MMP-12每升高1 ng/mL,AAA发生风险降低(OR=0.835,95%CI:0.752-0.926,P=0.001)。
  • MR分析未发现水平多效性或异质性(P>0.05)。

核心结论

  • TAA和AAA水平与血清MMP-12存在因果关联,MMP-12是降低AAA和TAA风险的因素,血清MMP-12水平与TAA和AAA风险降低存在因果关联。

研究设计与样本

  • 两样本孟德尔随机化研究,纳入欧洲血统人群中8种MMP(MMP-1、MMP-2、MMP-3、MMP-8、MMP-9、MMP-10、MMP-12、MMP-13)及TAA和AAA的全基因组关联研究数据(TAA与AAA分别来自FinnGen联盟,共3,201例病例和317,899例对照),共提取31个与MMP相关的单核苷酸多态性。

主要发现

  • 逆方差加权法显示TAA和AAA与血清MMP-12水平呈负向因果关联:血清MMP-12每升高1 ng/mL,TAA发生率降低1.031%(OR=0.897,95%CI:0.831-0.968,P=0.005)。
  • 血清MMP-12每升高1 ng/mL,AAA发生率降低1.653%(OR=0.835,95%CI:0.752-0.926,P=0.001)。
  • MR数据未发现水平多效性或异质性(P>0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Studies have linked matrix metalloproteinases (MMPs) to both thoracic aortic aneurysm and abdominal aortic aneurysm (TAA and AAA). The precise MMPs entailed in this procedure, however, were still unknown. This study used a two-sample Mendelian randomization (MR) analysis to look into the causal relationship between MMPs and the risk of TAA and AAA. METHODS: Eight MMPs, including MMP-1, MMP-2, MMP-3, MMP-8, MMP-9, MMP-10, MMP-12, and MMP-13, were found among people of European ancestry with accessible Genome-Wide Association Studies (GWAS). We employed the findings from Genome-Wide Association Studies (GWAS) for 8 MMPs, and TAA and AAA from the FinnGen consortiums (3,201 cases and 317,899 controls, respectively) were used in a two-sample MR analysis. The primary method of analysis for MR was the inverse variance weighted (IVW) method, along with analyses of heterogeneity and horizontal pleiotropy. 31 single-nucleotide polymorphisms connected to MMP were retrieved. RESULTS: IVW demonstrated a negative causal association between TAA and AAA and serum MMP-12 levels. The incidence of TAA decreased by 1.031% for every 1 ng/mL increase in serum MMP-12 [odds ratio (OR) = 0.897, 95% confidence interval (CI): 0.831-0.968, P = 0.005]. The incidence of AAA fell by 1.653% (OR = 0.835, 95% CI: 0.752-0.926, P = 0.001) for every 1 ng/mL increase in serum MMP-12. There was no horizontal pleiotropy or heterogeneity in the MR data (P > 0.05). CONCLUSIONS: The levels of TAA and AAA and serum MMP-12 are causally related. MMP-12 is a factor that reduces the risk of AAA and TTA. Our study suggested that MMP-12 level is causally associated with a decreased risk of TAA and AAA.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Qin T, Zhong J, Li P, et al. Matrix Metalloproteinase and Aortic Aneurysm: A Two-sample Mendelian Randomization Study. Ann Vasc Surg. 2024. PMID: 38609009. doi:10.1016/j.avsg.2024.02.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。